Evidence map›Paper›PMID 33216273›Full record

ArticleMycopathologia2021

Virulence Factors and Antifungal Susceptibility in Candida Species Isolated from Dermatomycosis Patients.

Victor Galvão Mello, Heloisa Escudeiro, Ana Carolina Villas Bôas Weckwerth, Maria Izilda Andrade, Ana Elisa Fusaro, Eloise Brasil de Moraes, Luciana da Silva Ruiz, Ida Maria Foschiani Dias Baptista

Abstract read
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Correlation Between Drug Resistance and Virulence ofInfection and drug resistance · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Victor Galvão MelloLauro de Souza Lima Institute, Bauru, Brazil.
Heloisa EscudeiroLauro de Souza Lima Institute, Bauru, Brazil.
Ana Carolina Villas Bôas WeckwerthLauro de Souza Lima Institute, Bauru, Brazil.
Maria Izilda AndradeLauro de Souza Lima Institute, Bauru, Brazil.
Ana Elisa FusaroLauro de Souza Lima Institute, Bauru, Brazil.
Eloise Brasil de MoraesLauro de Souza Lima Institute, Bauru, Brazil.ORCID http://orcid.org/0000-0003-1900-9788
Luciana da Silva RuizAdolfo Lutz Institute, Bauru, Brazil.ORCID http://orcid.org/0000-0001-7374-8640
Ida Maria Foschiani Dias BaptistaLauro de Souza Lima Institute, Bauru, Brazil. ifoschiani@gmail.com.ORCID http://orcid.org/0000-0002-1574-9490

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dermatomycoses caused by Candida spp. are increasingly common, however there are few reports in the literature regarding their epidemiology, pathogenesis and antifungal susceptibility of these fungal pathogens. This study aimed to identify, characterize virulence and determine the antifungal susceptibility of Candida species isolated from patients with dermatomycoses. We studied a total of 45 yeast samples isolated from dermal scrapings from patients treated at a public hospital, Bauru, São Paulo, Brazil. After identification, the samples were analyzed for protease activity, phospholipase, biofilm formation and antifungal susceptibility. The most common species was Candida albicans (40%), followed by C. krusei (22.22%), C. parapsilosis complex (22.22%) and C. famata (6.67%). Regarding virulence mechanisms, 57.78% and 28.89% of the samples showed enzymatic activity for protease and phospholipase, respectively. A total of 13.33% of the samples showed secretion of both enzymes. All isolates were biofilm producers, and a higher production was observed in C. tropicalis isolates. Regarding the antifungal susceptibility test, 97.78% of the samples had the highest levels of the minimal inhibitory concentration (MIC) for terbinafine, and one C. krusei sample showed intermediate susceptibility to fluconazole. The correct identification of dermatomycosis-related microorganisms, as well as a better knowledge of their pathogenicity and susceptibility against the antifungals used in the clinic, is extremely important for an efficient preventive and therapeutic action.

Indexed as

Antifungal AgentsDermatomycosesBrazilCandidaDrug Resistance, FungalHumansMicrobial Sensitivity TestsVirulence FactorsAntifungal AgentsVirulence FactorsAntifungalsCandida spp.DermatomycosesEpidemiologyPathogenesisVirulence

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.